Microbot Medical (MBOT) Short-term Investments (2010 - 2026)

Microbot Medical's Short-term Investments history runs 13 years deep, the most recent figure standing at $68.8 million for Q1 2026.

• Quarterly Short-term Investments rose 153.35% year-over-year to $68.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.8 million (up 153.35% YoY) and the FY2025 annual result came in at $74.7 million, up 3069.78% from the prior year.
• Short-term Investments was $68.8 million for Q1 2026 at Microbot Medical, down from $74.7 million in the prior quarter.
• Across five years, Short-term Investments topped out at $74.7 million in Q4 2025 and bottomed at $2.0 million in Q1 2022.
• A 5-year average of $18.7 million and a median of $4.2 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments sank 60.03% — and 2025, when it soared 3069.78%.
• Microbot Medical's Short-term Investments stood at $5.8 million in 2022, then tumbled by 32.0% to $3.9 million in 2023, then slumped by 39.85% to $2.4 million in 2024, then surged by 3069.78% to $74.7 million in 2025, then slipped by 7.82% to $68.8 million in 2026.
• Business Quant data shows MBOT's Short-term Investments at $68.8 million in Q1 2026, $74.7 million in Q4 2025, and $73.5 million in Q3 2025.